Metabolic effects of antihypertensive treatment
- 1 August 2003
- journal article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 21 (8) , 1459-1462
- https://doi.org/10.1097/00004872-200308000-00007
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololPublished by Elsevier ,2002
- Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)The Lancet, 2000
- Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty ratMetabolism, 1999
- Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trialThe Lancet, 1999
- ACE Inhibition But Not Angiotensin II Antagonism Reduces Plasma Fibrinogen and Insulin Resistance in Overweight Hypertensive PatientsJournal of Cardiovascular Pharmacology, 1998
- Normalization of Insulin Resistance in Non-Obese Essential Hypertension by Cilazapril TreatmentClinical and Experimental Hypertension, 1995
- Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid MetabolismDiabetes Care, 1991
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextPublished by Elsevier ,1990